(Q38378838)

2 September 2017

title

A cohort study of cervical screening using partial HPV typing and cytology triage (English)

1 reference

2 September 2017

1 reference

12

Nicolas Wentzensen

1 reference

2 September 2017

1

Mark Schiffman

1 reference

2 September 2017

11

Philip E Castle

1 reference

2 September 2017

Noorie Hyun

2

1 reference

2 September 2017

Tina R Raine-Bennett

3

1 reference

2 September 2017

Hormuzd Katki

4

1 reference

2 September 2017

Barbara Fetterman

5

1 reference

2 September 2017

Julia C Gage

6

1 reference

2 September 2017

Li C Cheung

7

1 reference

2 September 2017

Brian Befano

8

1 reference

2 September 2017

Nancy Poitras

9

1 reference

2 September 2017

Thomas Lorey

10

1 reference

2 September 2017

language of work or name

English

0 references

publication date

10 August 2016

1 reference

International Journal of Cancer

2 September 2017

published in

1 reference

2 September 2017

volume

139

1 reference

2 September 2017

issue

11

1 reference

2 September 2017

page(s)

2606-2615

1 reference

A review of human carcinogens--Part B: biological agents

2 September 2017

cites work

1 reference

Human papillomavirus and cervical cancer

21 January 2018

1 reference

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

21 January 2018

1 reference

Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test

21 January 2018

1 reference

Triage of HPV positive women in cervical cancer screening

21 January 2018

1 reference

Increased cervical cancer risk associated with screening at longer intervals.

21 January 2018

1 reference

A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results

21 January 2018

1 reference

A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results

21 January 2018

1 reference

New technologies and procedures for cervical cancer screening

21 January 2018

1 reference

Evaluation of a new DNA test for detection of carcinogenic human papillomavirus

21 January 2018

1 reference

Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens

21 January 2018

1 reference

21 January 2018

1 reference

Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California

21 January 2018

1 reference

Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting

21 January 2018

1 reference

Impact of 6-month frozen storage of cervical specimens in alkaline buffer conditions on human papillomavirus genotyping

21 January 2018

1 reference

Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort

21 January 2018

1 reference

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

21 January 2018

1 reference

Remission duration: an example of interval-censored observations.

21 January 2018

1 reference

Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model

21 January 2018

1 reference

Multiple imputation for threshold-crossing data with interval censoring

21 January 2018

1 reference

Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines

21 January 2018

1 reference

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

21 January 2018

1 reference

Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97.

21 January 2018

1 reference

Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer

21 January 2018

1 reference

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

21 January 2018

1 reference

Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results

21 January 2018

1 reference

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

21 January 2018

1 reference

Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection

21 January 2018

1 reference

Multiple biopsies and detection of cervical cancer precursors at colposcopy

21 January 2018

1 reference

Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive

21 January 2018

1 reference

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

21 January 2018

1 reference

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions

21 January 2018

1 reference

Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions

21 January 2018

1 reference

Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30375

1 reference

2 September 2017

1 reference